Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:43 PM
Ignite Modification Date:
2025-12-24 @ 6:43 PM
NCT ID:
NCT07106957
Eligibility Criteria:
Inclusion Criteria
* 18-55 years old
* Participants in the rosacea erythematous telangiectasia study or participants in the rosacea erythematous telangiectasia study who have not received treatment or have received treatment but are currently in a stable state (no treatment required). The treatment includes local medication, oral medication, phototherapy, or combined therapy
* The score of the Persistent Erythema Assessment Scale (CEA) is between 1 and 3 points
* The score of the Global Assessment Scale (IGA) is ≤2 points
* Dry facial skin
* People with sensitive skin (10% of those sensitive to lactic acid stinging)
Exclusion Criteria
* Intending to get pregnant, pregnant, lactating or within 6 months of delivery
* Research participants with other facial skin diseases (such as seborrheic dermatitis, systemic lupus erythematosus, facial miliform lupus, contact dermatitis, hormone-dependent dermatitis, etc.)
* Systemic diseases accompanied by severe organ damage, malignant tumors, chronic diseases with unstable control, acute infectious diseases, major surgeries or traumas, psychological and mental disorders, or other diseases that require local or systemic use of drugs or treatments that have an impact on acne
* The test area is accompanied by other skin diseases (dermatitis, eczema, infection, tumor, etc.) or has other skin conditions that interfere with evaluation (birthmarks, scars, etc.)
* Received physical, chemical or laser cosmetic surgery that is not for rosacea treatment within 3 months
* Subject who has participated in any clinical test during the past 2 month
* Others whose participation in the study is determined inappropriate by the dermatologist
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT07106957
Study Brief:
Protocol Section:
NCT07106957